IL-17 also leads to granulocyte colony stimulating factor (G-CSF)-mediated tumor-associated neutrophil expansion; blocking CCL2 in mice reduces the production of IL-17 by γδT17 cells, thus reducing the proliferation of neutrophils and enhancing the activity of CD8+ T cells. This evidence concerns the gene CSF3 and neoplasm.